SCHEMBL28503174

SCHEMBL28503174

CCC1CNCCN1C(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
PARP1 P09874 1/20 0.44
CYP2C19 P33261 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA4 P22748 2/20 0.44
CA9 Q16790 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28556404 1.00 HTR2C (0.54) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL13354770 0.89 CA1 (0.56) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL21590395 0.89 CA1 (0.56) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL21594461 0.89 CA1 (0.56) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL5506978 0.89 HTR2C (0.52) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL19696891 0.89 HTR2C (0.52) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL8715969 0.89 HTR2C (0.52) HTR2CSMN1; SMN2NPC1RAB9APARP1
Hydrochloric Acid SCHEMBL30632601 0.88 HTR2C (0.51) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL29724285 0.88 HTR2C (0.51) HTR2CSMN1; SMN2NPC1RAB9APARP1
SCHEMBL30292457 0.87 HTR2C (0.49) HTR2CSMN1; SMN2NPC1RAB9APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843856-B KRAS G12C inhibitors 米拉蒂治疗股份有限公司 2023-05-02 CN disclosed
CN-114867727-A TAU protein targeting compounds and related methods of use 阿尔维纳斯运营股份有限公司 2022-08-05 CN disclosed
CN-114787159-A BRM targeting compounds and related methods of use 阿尔维纳斯运营股份有限公司 2022-07-22 CN disclosed
CN-111989321-A KRAS G12C inhibitors 米拉蒂治疗股份有限公司 2020-11-24 CN disclosed